These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33558295)

  • 1. Efficacy and safety of oral fosfomycin for asymptomatic bacteriuria in kidney transplant recipients: Results from a Spanish multicenter cohort.
    Ruiz-Ruigómez M; Fernández-Ruiz M; Silva JT; Vidal E; Origüen J; Calvo-Cano A; Luna-Huerta E; Merino E; Hernández D; Jironda-Gallegos C; Escudero-Sánchez R; Gioia F; Moreno A; Roca C; Cordero E; Janeiro D; Sánchez-Sobrino B; Montero MM; Redondo D; Candel FJ; Pérez-Flores I; Armiñanzas C; González-Rico C; Fariñas MC; Rodrigo E; Loeches B; López-Oliva MO; Montejo M; Lauzurica R; Horcajada JP; Pascual J; Andrés A; Aguado JM; López-Medrano F;
    Antimicrob Agents Chemother; 2023 May; 95(5):. PubMed ID: 33558295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral fosfomycin for the treatment of lower urinary tract infections among kidney transplant recipients-Results of a Spanish multicenter cohort.
    López-Medrano F; Silva JT; Fernández-Ruiz M; Vidal E; Origüen J; Calvo-Cano A; Luna-Huerta E; Merino E; Hernández D; Jironda-Gallegos C; Escudero R; Gioia F; Moreno A; Roca C; Cordero E; Janeiro D; Sánchez-Sobrino B; Montero MM; Redondo D; Candel FJ; Pérez-Flores I; Armiñanzas C; González-Rico C; Fariñas MC; Rodrigo E; Loeches B; López-Oliva MO; Montejo M; Lauzurica R; Horcajada JP; Pascual J; Andrés A; Aguado JM;
    Am J Transplant; 2020 Feb; 20(2):451-462. PubMed ID: 31550408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fosfomycin-trometamol for Urinary Tract Infections in Kidney Transplant Recipients.
    Ten Doesschate T; van Werkhoven H; Meijvis S; Stalenhoef J; van Zuilen A; de Vries A; Bonten M
    Transplantation; 2019 Jun; 103(6):1272-1276. PubMed ID: 30130327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: narrowing of the therapeutic options.
    Origüen J; Fernández-Ruiz M; López-Medrano F; Ruiz-Merlo T; González E; Morales JM; Fiorante S; San-Juan R; Villa J; Orellana MÁ; Andrés A; Aguado JM
    Transpl Infect Dis; 2016 Aug; 18(4):575-84. PubMed ID: 27373698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fosfomycin susceptibility among multidrug-resistant, extended-spectrum beta-lactamase-producing, carbapenem-resistant uropathogens.
    Banerjee S; Sengupta M; Sarker TK
    Indian J Urol; 2017; 33(2):149-154. PubMed ID: 28469304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial.
    Sojo-Dorado J; López-Hernández I; Rosso-Fernandez C; Morales IM; Palacios-Baena ZR; Hernández-Torres A; Merino de Lucas E; Escolà-Vergé L; Bereciartua E; García-Vázquez E; Pintado V; Boix-Palop L; Natera-Kindelán C; Sorlí L; Borrell N; Giner-Oncina L; Amador-Prous C; Shaw E; Jover-Saenz A; Molina J; Martínez-Alvarez RM; Dueñas CJ; Calvo-Montes J; Silva JT; Cárdenes MA; Lecuona M; Pomar V; Valiente de Santis L; Yagüe-Guirao G; Lobo-Acosta MA; Merino-Bohórquez V; Pascual A; Rodríguez-Baño J;
    JAMA Netw Open; 2022 Jan; 5(1):e2137277. PubMed ID: 35024838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms.
    Neuner EA; Sekeres J; Hall GS; van Duin D
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5744-8. PubMed ID: 22926565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Oral Fosfomycin-Trometamol in Male Urinary Tract Infections with Multidrug-Resistant Enterobacterales.
    Bouiller K; Zayet S; Lalloz PE; Potron A; Gendrin V; Chirouze C; Klopfenstein T
    Antibiotics (Basel); 2022 Feb; 11(2):. PubMed ID: 35203801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria.
    Keating GM
    Drugs; 2013 Nov; 73(17):1951-66. PubMed ID: 24202878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should Asymptomatic Bacteriuria Be Systematically Treated in Kidney Transplant Recipients? Results From a Randomized Controlled Trial.
    Origüen J; López-Medrano F; Fernández-Ruiz M; Polanco N; Gutiérrez E; González E; Mérida E; Ruiz-Merlo T; Morales-Cartagena A; Pérez-Jacoiste Asín MA; García-Reyne A; San Juan R; Orellana MÁ; Andrés A; Aguado JM
    Am J Transplant; 2016 Oct; 16(10):2943-2953. PubMed ID: 27088545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the urinary tract infection caused by carbapenem-resistant Gram-negative bacilli impact the outcome of kidney transplant recipients?
    Freire MP; Mendes CV; Piovesan AC; de Paula FJ; Spadão F; Nahas WC; David-Neto E; Pierrotti LC
    Transpl Infect Dis; 2018 Aug; 20(4):e12923. PubMed ID: 29797681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral and Intravenous Fosfomycin for the Treatment of Complicated Urinary Tract Infections.
    Zhanel GG; Zhanel MA; Karlowsky JA
    Can J Infect Dis Med Microbiol; 2020; 2020():8513405. PubMed ID: 32300381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of fosfomycin for multidrug-resistant gram-negative infections.
    Bassetti M; Graziano E; Berruti M; Giacobbe DR
    Curr Opin Infect Dis; 2019 Dec; 32(6):617-625. PubMed ID: 31567411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic Treatment Versus No Treatment for Asymptomatic Bacteriuria in Kidney Transplant Recipients: A Multicenter Randomized Trial.
    Sabé N; Oriol I; Melilli E; Manonelles A; Bestard O; Polo C; Los Arcos I; Perelló M; Garcia D; Riera L; Tebé C; Len Ò; Moreso F; Cruzado JM; Carratalà J
    Open Forum Infect Dis; 2019 Jun; 6(6):ofz243. PubMed ID: 31214630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficiency of fosfomycin trometamol for treatment of acute uncomplicated cystitis].
    Kuzmenko AV; Kuzmenko VV; Gyaurgiev TA
    Urologiia; 2018 Dec; (6):70-75. PubMed ID: 30742381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing mortality in abdominal solid organ transplant recipients with multidrug-resistant gram-negative bacteremia.
    Qiao B; Wu J; Wan Q; Zhang S; Ye Q
    BMC Infect Dis; 2017 Feb; 17(1):171. PubMed ID: 28241746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymptomatic bacteriuria in pediatric kidney transplant recipients: to treat or not to treat? A retrospective study.
    Bonnéric S; Maisin A; Kwon T; Deschênes G; Niel O
    Pediatr Nephrol; 2019 Jun; 34(6):1141-1145. PubMed ID: 30820703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and outcome of antimicrobial resistance to gram-negative pathogens in bacteriuric kidney transplant recipients.
    Delmas-Frenette C; Dorais M; Tavares-Brum A; Frenette C; Yang B; Medani S; Duclos A; Rouleau D; Mawad H; Barama A; Cardinal H
    Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28486744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral fosfomycin for treating lower urinary tract infections due to multidrug-resistant
    Polat M; Ozkaya-Parlakay A; Tapısız A; Kara SS; Yüksel S
    J Chemother; 2022 Apr; 34(2):97-102. PubMed ID: 34286658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.